That's as near as dammit the same as the figures I've seen which came from Teather and Greenwood so my guess is that GCI used that note as the source for their rec.
The more I look through the rns since they floated the more excited I become, I'm no expert but the management do seem to be really on the ball and this one statement by the MD from last years finals is a peach.
-------------------------------------------------------------------------------
Outlook
In our first year as a public traded company, I see a burgeoning renewed organic growth rising beneath us, lifting sales and profitability; and a plethora of opportunities before us, with the wherewithal to realistically achieve what we can accurately qualify and prosecute. I have no doubt that Immunodiagnostic Systems Holdings plc is consolidating its' foundations, creating tomorrows' winning Team, and is now poised for a step change in growth and development that will deliver impressive growth in shareholder value.
Dr Roger Duggan
Managing Director
-------------------------------------------------------------------------------
OK! it's a little bit OTT but I'm convinced. I think I'm gonna buy in anyway, a few at a time. With so few shares available to PI's too many above NMS will command a premium just hope it doesn't break out over the £1.15 fingers pointed out while I'm doing it.